Search results for Solitomab
Solitomab Biosimilar – Anti-CD3E, EpCAM mAb – Research Grade, ProteoGenix, PX-TA1282
Description of Solitomab Biosimilar - Anti-CD3E, EpCAM mAb - Research Grade General information on Anti-CD3E/EpCAM[Homo sapiens] (Solitomab) Monoclonal Antibody Solitomab has been investigated for the treatment of Lung Cancer, Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer.
Host
Reactivity
Applications
Conjugation
Solitomab, Abbexa, abx831239
Solitomab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/EpCAM, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Mouse
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Research Grade Solitomab (HB104076), abinScience, HB104076
Host
Mouse
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.